Together with the observed reduction in cell proliferation and increased rates of apoptosis upon SSX knockdown, this accounts for the reduced capacity of SSX-silenced FM79 cells to form metastatic lesions in vivo and supports a role for SSX family members in melanoma progression. This evidence concerns the gene SSX2 and melanoma.